CNR Institutional Research Information System

LUVISETTO, SIRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.147
NA - Nord America 1.797
EU - Europa 841
SA - Sud America 756
AF - Africa 64
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.613
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.718
SG - Singapore 1.690
CN - Cina 1.035
BR - Brasile 620
VN - Vietnam 434
HK - Hong Kong 366
KR - Corea 233
FR - Francia 227
IT - Italia 215
JP - Giappone 93
DE - Germania 87
NL - Olanda 73
IN - India 71
BD - Bangladesh 62
FI - Finlandia 57
GB - Regno Unito 52
AR - Argentina 49
CA - Canada 33
IL - Israele 28
EC - Ecuador 24
ID - Indonesia 23
MX - Messico 23
ES - Italia 22
ZA - Sudafrica 21
AT - Austria 18
TR - Turchia 17
CO - Colombia 16
CL - Cile 13
RU - Federazione Russa 12
IQ - Iraq 11
MA - Marocco 11
PK - Pakistan 11
PL - Polonia 11
VE - Venezuela 11
PE - Perù 10
UZ - Uzbekistan 10
IE - Irlanda 9
PY - Paraguay 9
SA - Arabia Saudita 9
SE - Svezia 9
EG - Egitto 8
UA - Ucraina 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
PH - Filippine 6
TN - Tunisia 6
AU - Australia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LB - Libano 4
SI - Slovenia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AL - Albania 3
AZ - Azerbaigian 3
BE - Belgio 3
GR - Grecia 3
HN - Honduras 3
JM - Giamaica 3
KH - Cambogia 3
MY - Malesia 3
OM - Oman 3
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
JO - Giordania 2
LT - Lituania 2
MD - Moldavia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
GA - Gabon 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
Totale 7.606
Salva come PNG Salva come JPEG
Città #
Singapore 1.021
Santa Clara 593
Hefei 520
Hong Kong 360
Seoul 228
San Jose 219
Lauterbourg 198
Ho Chi Minh City 157
Beijing 155
Ashburn 122
Dallas 122
Hanoi 83
Rome 77
Los Angeles 74
Tokyo 61
São Paulo 60
Helsinki 44
Frankfurt am Main 32
New York 32
Minamishinagawa 29
Bengaluru 24
Buffalo 21
Da Nang 18
Boardman 16
Haiphong 16
Hải Dương 16
Milan 16
Orem 16
Belo Horizonte 14
London 14
Nuremberg 14
Rio de Janeiro 14
Vienna 14
Atlanta 13
Biên Hòa 13
Dhaka 13
Düsseldorf 13
Amsterdam 12
Chennai 11
Johannesburg 11
Guangzhou 10
Montreal 10
Tashkent 10
Brasília 9
Campinas 9
Can Tho 9
Council Bluffs 9
Curitiba 9
Falkenstein 9
Paris 9
Warsaw 9
Ninh Bình 8
Portsmouth 8
Thái Nguyên 8
Cabo Frio 7
Chicago 7
Dublin 7
Goiânia 7
Guarulhos 7
Guayaquil 7
Lappeenranta 7
Munich 7
Nairobi 7
Phoenix 7
Quito 7
Ribeirão Preto 7
Salvador 7
Shanghai 7
Boston 6
Buenos Aires 6
Bắc Giang 6
Cairo 6
Denver 6
Lima 6
Madrid 6
Porto Alegre 6
Sorocaba 6
Stockholm 6
São Gonçalo 6
Toronto 6
Bogotá 5
Brooklyn 5
Bắc Ninh 5
Ha Long 5
Hyderabad 5
Istanbul 5
Juiz de Fora 5
Manchester 5
New Delhi 5
Phủ Lý 5
Recife 5
San Antonio 5
San Francisco 5
The Dalles 5
Turku 5
Vĩnh Long 5
Ankara 4
Baghdad 4
Brescia 4
Canoas 4
Totale 4.878
Salva come PNG Salva come JPEG
Nome #
2023Pdm3 March 30 - Abstract 47 Estrogens recover muscle regeneration impaired by the pathogenic gene, DUX4, in orthotopic human xenograft 114
Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice. 113
SNAP25 CLEAVAGE BY BOTULINUM NEUROTOXIN-A REPROGRAMS SCHWANN CELLS INTO A PROREGENERATIVE PHENOTYPE 107
Pharmacological Interaction of Botulinum Neurotoxins with Excitatory and Inhibitory Neurotransmitter Systems Involved in the Modulation of Inflammatory Pain 98
Lack of cyclin D3 induces skeletal muscle fiber-type shifting, increased endurance performance and hypermetabolism 96
Effects of age-related loss of P/Q-type calcium channels in a mice model of peripheral nerve injury 94
Botulinum Neurotoxins beyond Neurons: Interplay with Glial Cells 93
Analgesic effects of botulinum neurotoxin type A in a model of allyl isothiocyanate- and capsaicin-induced pain in mice 90
Promising therapeutic applications of botulinum neurotoxins: nerve regeneration and functional recovery in a spinal cord injury mouse model. 89
Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy 87
BoNT-A as a Possible Treatment fo Chronic Spinal Cord Injury 86
Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model 84
Pain-related behaviours in mice lacking the CaV2.1alpha1 subunit of PQ-type Ca2+ channels 82
Central injection of botulinum neurotoxins: toxicology, brain localization and bahavioural effects in mice 79
The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors 78
Estrogenic hormones counteract FSHD features in a mouse model of muscle regeneration. 73
Botulinum Toxins: New Uses in the Treatment of Diseases 73
Study of regenerative potential of human perivascular cells expressing DUX4 73
Local protons and uncoupling of aerobic and artificial ???H-driven ATP synthesis 72
Xeomin((R)), a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury 70
Cyclin D3 deficiency promotes a slower, more oxidative skeletal muscle phenotype and ameliorates pathophysiology in the mdx mouse model of Duchenne muscular dystrophy 69
Altered pain sensitivity in mice lacking the CaV2.1alpha1 subunit of P/Q-type Ca2+ channels 68
Estrogen rescues muscle regeneration impaired by DUX4 in a humanized xenograft mouse model 68
Proton leaks, pump slips and hyperthyroidism. 67
Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice 66
Botulinum toxin type a as a therapeutic agent against headache and related disorders 66
PERMEABILITY OF THE INNER MITOCHONDRIAL MEMBRANE AND RESPIRATION 64
The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord 63
Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice. 62
Nuova applicazione terapeutica della neurotossina botulinica sierotipo A 61
Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain 61
Re-programming utrophin gene expression in DMD using artificial transcription factors 61
EFFECTS OF BOTULINUM NEUROTOXIN TYPE B IN NEUROPATHIC MICE: BEHAVIORAL AND IMMUNOHISTOCHEMICAL INVESTIGATIONS 60
The role of glial cells in the experience of pain: how much is important the sex factor? 59
Modulatory action of botulinum toxin type A on neuropathic pain: behavioral and immunohistochemical studies in animal models 58
Central injection of botulinum neurotoxins: behavioural effects in mice. 58
Introduction to the Toxins Special Issue on Botulinum Neurotoxins in the Nervous System: Future Challenges for Novel Indications. 58
Single channel biophysical properties of wild-type and mutant human P/Q-type calcium channels. 57
Altered cerebellum development and impaired motor coordination in mice lacking the Btg1 gene: Involvement of cyclin D1. 57
Habit learning in the cross maze: a cross talk between the context and the goal for action control. 56
Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy 56
Tracking of proton flow during transition from anaerobiosis to static head in rat liver mitochondria. 55
Sex differences and modulatory effect of 17beta-estradiol on behavioral and immune responses in neuropathic mice. 54
Przeciwbólowe efekty toksyny botulinowej A w szczurzym modelu bólu neuropatycznego. 53
The influence of BoNT/A administration on IL-1 family members in rat neuropathic pain model - in vivo and in vitro evidences. 52
Experimental gene therapy of Duchenne Muscular Dystrophy by artificial transcription factors upregulating the dystrophin-related gene Utrophin 52
17beta-estradiol counteracts neuropathic pain: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice. 51
Esano e suoi derivati: disaccoppiamento della catena respiratoria mitocondriale. 50
Botulinum Neurotoxins and Nervous System: Future Challenges for Novel Indications 50
Botulinum neurotoxin A promotes functional recovery after peripheral nerve injury by increasing regeneration of myelinated fibers 49
A new clinical relevant murine model of spinal cord injury mimicking the pathological features of complete paralysis in humans. 48
Higher pain perception and lack of recovery from neuropathic pain in females: A behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice 48
Rac-dependent pathway and cytoskeleton remodeling: a newintracellular mechanism for modulation of inflammatory pain 47
Introduction to the Toxins Special Issue on Botulinum Toxins: New Uses in the Treatment of Diseases 47
Botulinum toxin and neuronal regeneration after traumatic injury of central and peripheral nervous system 47
Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. 46
Novel Adeno-Associated Viral Vector Delivering the Utrophin Gene Regulator Jazz Counteracts Dystrophic Pathology in mdx Mice 46
CNF1 BACTERIAL TOXIN PROTEIN FROM E. COLI AS ANALGESIC 45
Modal gating of human CaV2.1 (P/Q-type) calcium channels: I. The slow and the fast gating modes and their modulation by beta subunits. 45
Experimental gene therapy of Duchenne Muscular Dystrophy by artificial transcription factors upregulating the dystrophin-related gene Utrophin 44
Pathways implicated in tadalafil amelioration of Duchenne Muscular Dystrophy 43
Free energy coupling: from phases to molecules. 42
COMPOSITION AND METHODS FOR TREATMENT OF MUSCULAR DYSTROPHY (EP3194600B1) 42
Effects of Botulinum Toxin on Functional Recovery after Injures of Nervous System 42
Disaccoppiamento della fosforilazione ossidativa indotto da FCCP, cloroformio e acido oleico in rat liver mitochondria 41
COMPOSITION AND METHODS FOR TREATMENT OF MUSCULAR DYSTROPHY (US10301367B2) 41
Altered sensitivity to nociceptive stimuli in mice lacking the CaV2.1 alpha1 subunit of P/Q-type Ca2+ channels. 41
Modulatory action of botulinum toxin type A on neuropathic pain; insights from animal models. 40
Remission of hair loss and induction of hair regrowth by botulinum neurotoxin A in mice 40
Pain sensitivity in mice lacking the Ca(v)2.1alpha1 subunit of P/Q-type Ca2+ channels. 40
Tyr682 in the Abeta-precursor protein intracellular domain regulates synaptic connectivity, cholinergic function, and cognitive performance 40
Cognitive and neural determinants of response strategy in the dual-solution plus-maze task 40
The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice. 39
The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice 37
The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes 37
Botulinum neurotoxin serotype A: an innovative pharmacological approach for pain treatment. 36
PH dependence of human CaV2.1 channels and its alteration by a familial hemiplegic migraine mutation. 36
Is the retrograde transport of botulinum neurotoxin type A involved in its analgesic effects on neuropathic pain? 35
Botulinum neurotoxin serotype A improves behavioural responses and peripheral nerve regeneration in a mouse model of neuropathic pain 35
Introduction to Toxins Special Issue on Botulinum Toxins: New Uses in the Treatment of Diseases (2nd Edition) 34
Central injection of botulinum neurotoxins: toxicology and behavioural effects in mice 33
ANIMAL MODELS TO VALIDATE THE USE OF NEW SMALL SYNTHETIC TRANSCRIPTION FACTORS IN THE GENE THERAPY OF MUSCLE DYSTROPHIES 33
Toxicological and behavioural effects of botulinum neurotoxins injected in central nervous system 33
Modal gating of human CaV2.1 (P/Q-type) calcium channels: I. The slow and the fast gating modes and their modulation by β subunits 33
pH dependence of human CaV2.1 channels and its alteration by a familial hemiplegic migraine mutation 32
Modal gating of human Cav2.1 (P/Q-type) calcium channels. II. The b mode and reversible uncoupling of inactivation 32
Altered sensitivity to nociception stimuli in mice lacking the CaV2.1alpha1 subunit of PQ-type Ca2+ channels 32
Toxicity of botulinum neurotoxins in central nervous system of mice 31
The mechanism of uncoupling of oxidative phosphorylation. 31
Nature of respiratory stimulation in hyperthyroidism: the redox behaviour of cytochrome c 30
Enhancement of anxiety, facilitation of avoidance behavior, and occurrence of adult-onset obesity in mice lacking mitochondrial cyclophilin D 30
Botulinum neurotoxin serotype A and morphine: a successful pharmacological combination for treating inflammatory pain 30
Behavioral and immunohistochemical sex-related differences in neuropathic mice. 30
Selectivity and pH-dependence of human CaV2.1 channels and their alterations produced by mutations linked to familial hemiplegic migraine 29
Anomalous L-type calcium channels of rat spinal motoneurons 29
The distinction between leaks and slips. 29
Utrophin up-regulation mediated by an artificial transcription factor ameliorates the dystrophic symptoms in mdx mice. 29
THE REDOX STATE OF CYTOCHROMES AS A NEW TOOL TO ASSESS THE THERMODYNAMIC STATE OF MITOCHONDRIA 29
The effect of botulinum neurotoxin A on CCI-Induced neuroimmunological chnages in DRG and spinal cord 28
Familial hemiplegic migraine mutations increase Ca2+ influx through single human Cay2.1 channels and decrease maximal Cay2.1 current density in neurons. 28
Totale 5.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.561
article - articoli 11.525
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 776
Totale 35.862
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202484 0 0 0 0 0 0 0 0 6 3 58 17
2024/20252.697 15 13 202 124 526 122 37 120 64 103 711 660
2025/20264.898 268 688 579 751 811 159 743 238 232 255 116 58
Totale 7.679